Correlation Between Eton Pharmaceuticals and Travere Therapeutics

Can any of the company-specific risk be diversified away by investing in both Eton Pharmaceuticals and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eton Pharmaceuticals and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eton Pharmaceuticals and Travere Therapeutics, you can compare the effects of market volatilities on Eton Pharmaceuticals and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eton Pharmaceuticals with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eton Pharmaceuticals and Travere Therapeutics.

Diversification Opportunities for Eton Pharmaceuticals and Travere Therapeutics

0.52

Correlation Coefficient

Eton Pharmaceuticals  Travere Therapeutics

Very weak diversification

The 3 months correlation between Eton and Travere is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Eton Pharmaceuticals and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Eton Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eton Pharmaceuticals are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Eton Pharmaceuticals i.e., Eton Pharmaceuticals and Travere Therapeutics go up and down completely randomly.

Pair Corralation between Eton Pharmaceuticals and Travere Therapeutics

Given the investment horizon of 90 days Eton Pharmaceuticals is expected to generate 0.98 times more return on investment than Travere Therapeutics. However, Eton Pharmaceuticals is 1.02 times less risky than Travere Therapeutics. It trades about 0.3 of its potential returns per unit of risk. Travere Therapeutics is currently generating about 0.16 per unit of risk. If you would invest  343.00  in Eton Pharmaceuticals on October 7, 2024 and sell it today you would earn a total of  957.00  from holding Eton Pharmaceuticals or generate 279.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Eton Pharmaceuticals  vs.  Travere Therapeutics

Eton Pharmaceuticals

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Eton Pharmaceuticals are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Eton Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Travere Therapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Travere Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Travere Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Eton Pharmaceuticals and Travere Therapeutics

The main advantage of trading using opposite Eton Pharmaceuticals and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eton Pharmaceuticals position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.

The idea behind Eton Pharmaceuticals and Travere Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.